Sumeet Gandhi1, Shaun G Goodman1, Nicola Greenlaw2, Ian Ford2, Paula McSkimming2, Roberto Ferrari3, Yangsoo Jang4, Marco Antonio Alcocer-Gamba5, Kim Fox6, Jean-Claude Tardif7, Michal Tendera8, Paul Dorian1, Gabriel Steg6,9, Jacob Allan Udell10. 1. Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. 2. Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom. 3. Department of Cardiology and LTTA Centre, University Hospital of Ferrara and Maria Cecilia Hospital, Cotignola, Italy. 4. Severance Cardiovascular Hospital, Yonsei College of Medicine, Seoul, South Korea. 5. Jefe de Cardiología Intervencionista, Universidad Autónoma de Querétaro, Querétaro, Mexico. 6. Institute of Cardiovascular Medicine and Science, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, United Kingdom. 7. Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada. 8. Medical University ofSilesia, School of Medicine in Katowice, Katowice, Poland. 9. French Alliance for Cardiovascular Trials, an F-CRIN network, Université Paris-Didero, AP-HP and INSERM U1148, Paris, France. 10. Peter Munk Cardiac Centre and Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
Authors: Robin L A Smits; Laura H van Dongen; Marieke T Blom; Hanno L Tan; Irene G M van Valkengoed Journal: J Epidemiol Community Health Date: 2022-07-01 Impact factor: 6.286